p53 tumor suppressor gene — Drug Target
All drugs that target p53 tumor suppressor gene — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- rAd-p53 gene · Shenzhen SiBiono GeneTech Co.,Ltd · Gene therapy; oncolytic virus · Oncology
rAd-p53 is a recombinant adenovirus carrying the wild-type p53 tumor suppressor gene that restores p53 function in cancer cells to induce apoptosis and inhibit tumor growth.